BioSpace News Archive

Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5

Rafarma Pharmaceuticals, Inc. OTC: reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest pharmaceutical companies in Russia for 2020, showing incredible growth rates with a net profit increase of 220.9% compared to 2019.

November 19, 2021
·
2 min read
LevitasBio Announces New Integrated Approaches to Sample Preparation and Cell Enrichment

LevitasBio has announced the expansion of its product portfolio with the release of two new product lines that will enable researchers and laboratory personnel to better process and characterize human, animal and plant samples.

November 19, 2021
·
3 min read
Health Canada authorizes use of Comirnaty (the Pfizer-BioNTech COVID-19 vaccine) in children 5 to 11 years of age

Today, Health Canada authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age.

November 19, 2021
·
1 min read
Business

Invitation to presentation of the Q3 2021 results

Oncopeptides AB will publish its report for the third quarter 2021 on November 24 . Investors, financial analysts, and media are invited to participate in a webcast with a Q&A session on the same day at 10:00 CET.

November 19, 2021
·
2 min read
Job Trends

Zymeworks Announces Abstract for Zanidatamab in Late-Line HER2-Positive Breast Cancer at the San Antonio Breast Cancer Symposium (SABCS)

Zymeworks Inc. (NYSE: ZYME), today announced the publication of an abstract highlighting new clinical data for zanidatamab, a HER2-targeted bispecific antibody.

November 19, 2021
·
6 min read
Drug Development

Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients

Jaguar Health, Inc. announced topline results of the third-party, investigator-initiated Phase 2 HALT-D trial evaluating crofelemer for the prevention of chemotherapy-induced diarrhea in HER2-positive breast cancer patients being treated with trastuzumab, pertuzumab and a taxane.

November 19, 2021
·
10 min read
Job Trends

Pfizer and BioNTech Receive Health Canada Authorization of COVID-19 Vaccine COMIRNATY in Children Ages 5 Through &12 Years

Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized COMIRNATY, the companies’ COVID-19 vaccine for children 5 to under 12 years of age .

November 19, 2021
·
3 min read
BioForest

Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cancer Symposium

Seagen, Inc. (Nasdaq:SGEN) today announced upcoming data presentations for TUKYSA® (tucatinib) at the San Antonio Breast Cancer Symposium (SABCS), taking place December 7-10, 2021.

November 19, 2021
·
12 min read
Business

Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium

Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) announced today that updated safety and efficacy data from the Phase 1 dose escalation trial of ARV-471 will be presented in a spotlight poster-discussion session at the 2021 San Antonio Breast Cancer Symposium (SABCS) on December 7-10, 2021.

November 19, 2021
·
9 min read
Business

Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, has announced the appointment of Bob Silverman as Chief Business Officer (CBO).

November 19, 2021
·
2 min read